Biopharma's Hiring Blind Spots Have a Familiar Pattern
TL;DR
Biopharma leaders routinely conflate deep scientific expertise with leadership readiness, treat hiring as an improvised event rather than a repeatable process, and end up with costly mis-hires at the functional leadership level. The pattern is well-documented — and largely avoidable.
Context
Executive search consultant Michael Pietrack at Kaye/Bassman International published a breakdown of recurring hiring errors among biopharma executives, drawing on his work in leadership recruiting and conversations from The Pharmaverse Podcast. The piece targets C-suite and VP-level decision-makers filling critical functional roles — the kind of positions where a wrong hire can stall a program or fracture a team for years.
Analysis
The central argument is straightforward: organizations in life sciences have a talent bias problem. Because scientific credibility is the currency of the industry, executives frequently promote or recruit for domain mastery when they actually need someone who can build and run a team. Those are different skill sets, and treating them as interchangeable is where things break down.
The second failure mode is structural. Many biopharma organizations have no defined hiring process — no consistent interview framework, no clear ownership of the final decision, no deliberate sourcing strategy beyond an executive’s existing network. When hiring is ad hoc, outcomes are inconsistent by default.
Pietrack’s prescription is practical: hire functional leaders who have demonstrated team-building experience, broaden candidate sourcing beyond the familiar rolodex, use a structured interview panel while keeping decision authority clear, and treat the hiring process itself as something worth designing. That last point is worth sitting with — most orgs invest heavily in their research processes and almost nothing in their people-acquisition processes, even when the stakes are equivalent.
The through-line here isn’t unique to biopharma. Product and design orgs face the same trap: the senior IC who’s exceptional at craft gets moved into a leadership role with no scaffolding, and six months later everyone’s wondering why the team is underperforming. Industry context differs, but the underlying error is identical.
Takeaways
- Expertise ≠ leadership readiness. Evaluate candidates on their track record of building and developing teams, not just their technical depth.
- Hiring needs a process, not improvisation. Defined steps, clear decision ownership, and structured interviews produce better outcomes than gut-driven, one-off searches.
- Network-only sourcing creates selection bias. Deliberately expanding the candidate pool surfaces people a narrow network would never surface.
- Empower or decide — but be explicit. Ambiguity about who owns the final call slows hiring and muddies accountability.
- Applicable beyond life sciences. Any domain that values craft expertise over management capability risks promoting the wrong people into leadership.
Source: BioSpace / Kaye/Bassman International